My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Recursion Pharmaceuticals LLC
Recent news which mentions Recursion Pharmaceuticals LLC
Cramer's Lightning Round: Rigetti Computing is 'a meme stock'
March 07, 2025
Tags
Stock markets
Fiserv Inc
Business News
From
CNBC.com News
Cramer's Lightning Round: Reddit is 'fabulous'
November 26, 2024
Tags
Mad Money
Investment strategy
Stock markets
From
CNBC.com News
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
October 02, 2024
Tags
AI / Artificial Intelligence
Exscientia PLC
Technology
From
CNBC.com News
Cramer's Lightning Round: 'Hold on to' Marvell Technology
June 27, 2024
Tags
Stock Picks
Market Outlook
Business
From
CNBC.com News
Cramer's Lightning Round: 'I would not be a buyer' of Corning
May 22, 2024
Tags
U/S/ Markets
Merit Medical Systems Inc
Business
From
CNBC.com News
Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly
May 10, 2024
Tickers
CEO
Tags
stocks
Investing
Markets
From
CNBC.com News
Cramer's Lightning Round: Broadcom is a buy
April 23, 2024
Tags
Casey's General Stores Inc
Recursion Pharmaceuticals LLC
Markets
From
CNBC.com News
Nvidia's AI ambitions in medicine and health care are becoming clear
March 24, 2024
Tags
Health Care IT
Technology
Technology Executive Council
From
CNBC.com News
Nvidia holdings disclosure pumps up shares of small AI companies
February 15, 2024
Tags
TuSimple Holdings Inc
Technology
SoundHound AI Inc
From
CNBC.com News
Top Wall Street analysts pick these stocks for solid returns
January 21, 2024
Tags
Commentary
Amazon/com Inc
U/S/ Markets
From
CNBC.com News
Nvidia invests $50 million in biotech company Recursion for AI drug discovery
July 12, 2023
Tags
Business News
Bayer AG
Moderna Inc
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.